hotspot -WSS

hotspot

author：knowledge 2025-10-02 22:58:38 - browse：99947

3D DNA on a sheet of paper listing nucleic acid sequences — coverage from STAT — Adobe

Ultima Genomics, an upstart some observers have called a “dark horse” in the world of DNA sequencing, will soon launch a line of high-power instruments that can read a human genome for as little as $100, the company’s leadership told STAT.

The sequencer, dubbed the UG 100, is a $1.5 million machine that can read up to 20,000 human genomes a year. The reagents required to operate the instrument cost as little as $1 per billion sequenced DNA bases; that translates to $100 per genome assuming each base in the 3-gigabase human genome is read 33 times, a common industry standard. The company plans to officially launch the product at this year’s Advances in Genome Biology and Technology meeting, which kicks off in Orlando, Fla., on Feb. 5.

The product’s cost and maximum output put it roughly in the same range as a line of high-throughput instruments launched in September 2022 by Illumina, which controls an estimated 80% of the sequencing market. But Ultima is hoping it can chip into the sequencing giant’s market share among genome centers, large clinical labs, and others with an appetite for reams of genetic data by offering lower operating costs and greater flexibility.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： George Santos makes 1st court appearance after pleading not guilty to 13 counts
Next article： Correcting Robert F. Kennedy Jr.'s vaccine 'facts'

WSS

Stem cell treatment guidelines are released by FDA

Snackable artificial intelligence, expert AI, and the pharma industry

Canadians with cystic fibrosis outlive Americans by a decade

A letter from the executive editor: The 2023 STATUS List

Grandmother of French teen shot dead by police officer pleads with rioters to stop the violence

Crinetics acromegaly drug succeeds in late

hotspot

hotspot

knowledge

Apple is now the first public company to be valued at $3 trillion

Archived: an online chat discussing Ebola, vaccines, and a new epidemic

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Penis shrinkage, a side effect of prostate cancer surgery, is temporary

BioMarin wins approval for gene therapy to treat hemophilia A

The 10 drugs up first for Medicare price negotiation

In Memoriam: Notable people who died in 2023

Canadians with cystic fibrosis outlive Americans by a decade

Medical leaders decry Supreme Court decision on affirmative action

Skip the lead apron during X

entertainment

Hubble vs. James Webb telescope images: See the difference

Being 'nonadherent' patient made me a more empathetic doctor

Security flaws in third

Listen: Biogen's potential pivot, & Illumina's next chapter

Illumina names Agilent executive as new CEO

Covid hospitalizations on the rise, Humana says

hotspot

hotspot

hotspot

hotspot